Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country

被引:33
|
作者
Javaid, Arshad [1 ]
Ahmad, Nafees [2 ,3 ]
Khan, Amer Hayat [2 ]
Shaheen, Zubair [4 ]
机构
[1] Lady Reading Hosp Peshawar, Dept Pulmonol, Peshawar, Pakistan
[2] Univ Sains Malaysia Pulau Pinang, Sch Pharmaceut Sci, Discipline Clin Pharm, Gelugor, Penang, Malaysia
[3] Univ Baluchistan, Fac Pharm & Hlth Sci, Quetta, Pakistan
[4] Nishtar Hosp, Dept Pulmonol, Multan, Pakistan
关键词
TREATMENT OUTCOMES; FLUOROQUINOLONES;
D O I
10.1183/13993003.01967-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
    Hassane-Harouna, Souleymane
    Cherif, Gba-Foromo
    Ortuno-Gutierrez, Nimer
    Cisse, Diao
    Camara, Lansana Mady
    Diallo, Boubacar Djelo
    Camara, Souleymane
    Bangoura, Adama Marie
    Lynen, Lutgarde
    Decroe, Tom
    PLOS ONE, 2020, 15 (08):
  • [42] High rates of multidrug-resistant tuberculosis in the country of Georgia: A population-based study.
    Lomtadze, N.
    Salakaia, A.
    Aspindzelashvili, R.
    Janjgava, M.
    Blumberg, H. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S284 - S284
  • [44] Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis
    V. Parums, Dinah
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [45] 'Need of the Hour': Early Diagnosis and Management of Multidrug Resistant Tuberculosis of the Spine: An Analysis of 30 Patients from a "High Multidrug Resistant Tuberculosis Burden" Country
    Arockiaraj, Justin
    Karthik, Rajiv
    Michael, Joy Sarojini
    Amritanand, Rohit
    David, Kenny Samuel
    Krishnan, Venkatesh
    Sundararaj, Gabriel David
    ASIAN SPINE JOURNAL, 2019, 13 (02) : 265 - 271
  • [46] Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil
    Salvato, R. S.
    Schiefelbein, S.
    Barcellos, R. B.
    Praetzel, B. M.
    Anusca, I. S.
    Esteves, L. S.
    Halon, M. L.
    Unis, G.
    Dias, C. F.
    Miranda, S. S.
    de Almeida, I. N.
    de Assis Figueredo, L. J.
    Silva, E. C.
    Kritski, A. L.
    Dalla Costa, E. R.
    Rossetti, M. L. R.
    EPIDEMIOLOGY AND INFECTION, 2019, 147
  • [47] Abandonment of therapy in multidrug-resistant tuberculosis: Associated factors in a region with a high burden of the disease in Peru
    Rivera, Oriana
    Benites, Santiago
    Mendigure, Julio
    Antonio Bonilla, Cesar
    BIOMEDICA, 2019, 39 : 44 - 57
  • [48] Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013
    Peng Ying
    Chen Song-Hua
    Zhang Le
    Chen Bin
    Zhang Ming-Wu
    He Tie-Niu
    Wang Fei
    Chai Cheng-Liang
    Zhou Lin
    Zhang Yu
    Wang Xiao-Meng
    Jia Zhongwei
    中华医学杂志英文版, 2016, 130 (17) : 2021 - 2026
  • [49] Cost-effectiveness of bedaquiline or delamanid plus background regimen for multidrug-resistant tuberculosis in a high-income intermediate burden city of China
    Fan, Qianqian
    Ming, Wai-kit
    Yip, Wai-ying
    You, Joyce H. S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 78 : 44 - 49
  • [50] Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013
    Peng, Ying
    Chen, Song-Hua
    Zhang, Le
    Chen, Bin
    Zhang, Ming-Wu
    He, Tie-Niu
    Wang, Fei
    Chai, Cheng-Liang
    Zhou, Lin
    Zhang, Yu
    Wang, Xiao-Meng
    Jia, Zhongwei
    CHINESE MEDICAL JOURNAL, 2017, 130 (17) : 2021 - 2026